OtherClinical Investigations (Human)
Increased P-gp inhibition at the human blood brain barrier can be safely achieved by performing PET during peak plasma concentrations of tariquidar
William Charles Kreisl, Ritwik Bhatia, Cheryl L. Morse, Alicia E. Woock, Sami S. Zoghbi, H. Umesha Shetty, Victor W Pike and Robert B. Innis
Journal of Nuclear Medicine December 2014, jnumed.114.146894; DOI: https://doi.org/10.2967/jnumed.114.146894
William Charles Kreisl
1 1. National Institute of Mental Health, 2) Columbia University Medical Center, United States;
Ritwik Bhatia
2 National Institute of Mental Health
Cheryl L. Morse
2 National Institute of Mental Health
Alicia E. Woock
2 National Institute of Mental Health
Sami S. Zoghbi
2 National Institute of Mental Health
H. Umesha Shetty
2 National Institute of Mental Health
Victor W Pike
2 National Institute of Mental Health
Robert B. Innis
2 National Institute of Mental Health

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
Increased P-gp inhibition at the human blood brain barrier can be safely achieved by performing PET during peak plasma concentrations of tariquidar
William Charles Kreisl, Ritwik Bhatia, Cheryl L. Morse, Alicia E. Woock, Sami S. Zoghbi, H. Umesha Shetty, Victor W Pike, Robert B. Innis
Journal of Nuclear Medicine Dec 2014, jnumed.114.146894; DOI: 10.2967/jnumed.114.146894
Increased P-gp inhibition at the human blood brain barrier can be safely achieved by performing PET during peak plasma concentrations of tariquidar
William Charles Kreisl, Ritwik Bhatia, Cheryl L. Morse, Alicia E. Woock, Sami S. Zoghbi, H. Umesha Shetty, Victor W Pike, Robert B. Innis
Journal of Nuclear Medicine Dec 2014, jnumed.114.146894; DOI: 10.2967/jnumed.114.146894
Jump to section
Related Articles
Cited By...
- Imaging the Activity of Efflux Transporters at the Blood-Brain Barrier in Neurologic Diseases: Radiotracer Selection Criteria
- Imaging P-Glycoprotein Induction at the Blood-Brain Barrier of a {beta}-Amyloidosis Mouse Model with 11C-Metoclopramide PET
- Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate 11C-Metoclopramide Assessed with PET Imaging in Humans
- A Proof-of-Concept Study to Inhibit ABCG2- and ABCB1-Mediated Efflux Transport at the Human Blood-Brain Barrier
- P-Glycoprotein (ABCB1) Inhibits the Influx and Increases the Efflux of 11C-Metoclopramide Across the Blood-Brain Barrier: A PET Study on Nonhuman Primates
- Strategies to Inhibit ABCB1- and ABCG2-Mediated Efflux Transport of Erlotinib at the Blood-Brain Barrier: A PET Study on Nonhuman Primates